19-929686-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005224.3(ARID3A):c.158G>A(p.Arg53Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000474 in 1,560,512 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005224.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARID3A | NM_005224.3 | c.158G>A | p.Arg53Gln | missense_variant | 2/9 | ENST00000263620.8 | NP_005215.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARID3A | ENST00000263620.8 | c.158G>A | p.Arg53Gln | missense_variant | 2/9 | 1 | NM_005224.3 | ENSP00000263620 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152154Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000963 AC: 16AN: 166104Hom.: 0 AF XY: 0.0000980 AC XY: 9AN XY: 91812
GnomAD4 exome AF: 0.0000419 AC: 59AN: 1408244Hom.: 0 Cov.: 74 AF XY: 0.0000373 AC XY: 26AN XY: 697318
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152268Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.158G>A (p.R53Q) alteration is located in exon 2 (coding exon 1) of the ARID3A gene. This alteration results from a G to A substitution at nucleotide position 158, causing the arginine (R) at amino acid position 53 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at